نتائج البحث - "Nicolas Mach"

1

A Functional GM-CSF Receptor on Dendritic Cells Is Required for Efficient Protective Anti-Tumor Immunity

المؤلفون: Nicolas Mach, Remi Vernet, Alena Donda, Frank Schwenter, P. Luy, Emily Charrier

المصدر: Immuno, Vol 1, Iss 16, Pp 240-252 (2021)
Immuno
Volume 1
Issue 3
Pages 16-252

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4d6547247a80743231c54c588aa15b7Test
https://www.mdpi.com/2673-5601/1/3/16Test

2

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study

المؤلفون: Burak Gumuscu, Kevin J. Harrington, Hoi-Shen Radcliffe, Lillian L. Siu, Wendy Snyder, Danny Rischin, Beatriz Castelo Fernandez, Ezra E.W. Cohen, Jason Chesney, Anthony Kong, Jonathan D. Cheng, Nicolas Mach

المصدر: Clinical Cancer Research, Vol. 26, No 19 (2020) pp. 5153-5161

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Herpesvirus 1, Human, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Refractory, Internal medicine, Multicenter trial, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Neoplasm Metastasis, Adverse effect, Aged, ddc:616, Oncolytic Virotherapy, Biological Products, Chemotherapy, Squamous Cell Carcinoma of Head and Neck, business.industry, Middle Aged, medicine.disease, Combined Modality Therapy, Head and neck squamous-cell carcinoma, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Immunotherapy, Neoplasm Recurrence, Local, Talimogene laherparepvec, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e68d707fa9e943a6b37439bfbf54a5aTest
https://doi.org/10.1158/1078-0432.ccr-20-1170Test

3

Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model

المؤلفون: Nicolas Mach, Ugo Tomasello, Rémi Vernet, Sabine Fievre, Erika Cosset, Emily Charrier, Julien Grogg

المصدر: Vaccines; Volume 9; Issue 5; Pages: 484
Vaccines
Vaccines, Vol. 9, No 5 (2021) P. 484
Vaccines, Vol 9, Iss 484, p 484 (2021)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da5a722c04272804a04d5a55b7b5453Test

4

Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial

المؤلفون: Paolo Bossi, Loris De Cecco, Vittoria Espeli, Silvana Canevari, Nicolas Mach, Michele Ghielmini, Marco Siano, Lisa Licitra, Milo Frattini

المصدر: Oral Oncology. 82:144-151

مصطلحات موضوعية: Microenvironment score, Male, 0301 basic medicine, Oncology, Cancer Research, Afatinib, medicine.medical_treatment, Antineoplastic Agents, Immunological, 0302 clinical medicine, 80 and over, Medicine, Head and neck cancer, Anti-EGFR, Gene expression signatures, Hypoxia signature, miRNA, Progression-free survival, Recurrent/metastatic, Second line treatment, Adult, Aged, Aged, 80 and over, Female, Head and Neck Neoplasms, Humans, MicroRNAs, Middle Aged, Panitumumab, Gene Expression Profiling, Cetuximab, Immunological, 030220 oncology & carcinogenesis, Oral Surgery, medicine.drug, medicine.medical_specialty, medicine.drug_class, Antineoplastic Agents, Monoclonal antibody, 03 medical and health sciences, Internal medicine, microRNA, Chemotherapy, business.industry, medicine.disease, 030104 developmental biology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf071d5218ee9736c0b00bda2038a3fcTest
https://doi.org/10.1016/j.oraloncology.2018.05.013Test

5

MVX-ONCO-1 in advanced refractory cancers: Safety, feasibility, and preliminary efficacy results from all HNSCC patients treated in two ongoing clinical trials

المؤلفون: Denis Migliorini, Nicole Grandjean, Nicolas Mach, Muriel Urwyler, Jean Villard, Emily Charrier, Virginie Ancrenaz, Olivier von Rohr, Elisabeth Lafferma, Emmanuel Lavalliere, Julien Grogg, Eugenio Fernandez, Markus Joerger, Valentin Saingier, Remi Vernet, Olivier Rubin, Marie-Claude Belkouch

المصدر: Journal of Clinical Oncology. 39:e18005-e18005

مصطلحات موضوعية: Clinical trial, Cancer Research, Oncology, Cancer immunotherapy, Refractory, Genetically engineered, business.industry, medicine.medical_treatment, medicine, Cancer research, business, MVX-ONCO-1, Autologous tumor

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fe2027bf57910828583ea36341cff6f9Test
https://doi.org/10.1200/jco.2021.39.15_suppl.e18005Test

6

Final analysis of a phase 1b, randomized, multicenter study of talimogene laherparepvec (T-VEC) plus pembrolizumab (pembro) combination for the treatment (Tx) of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC): MASTERKEY-232

المؤلفون: Ezra E.W. Cohen, Danny Rischin, Burak Gumuscu, Kevin J. Harrington, Nicolas Mach, Lillian L. Siu, Beatriz Castelo, Anthony Kong, Jason Chesney, Hoi-Shen Radcliffe, Wendy Snyder

المصدر: Journal of Clinical Oncology. 39:6036-6036

مصطلحات موضوعية: Cancer Research, business.industry, medicine.medical_treatment, Pembrolizumab, Immunotherapy, Genetically modified organism, Oncolytic virus, Immune system, Oncology, Multicenter study, Cancer research, medicine, Head and neck, Talimogene laherparepvec, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0b70ff3576aa085adc3083c112c38b12Test
https://doi.org/10.1200/jco.2021.39.15_suppl.6036Test

7

Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17

المؤلفون: Zuzanna Maniecka, Nicolas Mach, Miklos Pless, Roland Seiler, Stefanie Aeppli, Martin Spahn, Raeto Strebel, Ulf Petrausch, Sacha I. Rothschild, Mathias Schmid, Martina Schneider, Dominik Berthold, Boris A. Hadaschik, Andreas Erdmann, Richard Cathomas, Stefanie Hayoz, Julian Schardt, Deborah Zihler

المصدر: Journal of Clinical Oncology. 39:430-430

مصطلحات موضوعية: Cisplatin, Cancer Research, Chemotherapy, Durvalumab, business.industry, Immune checkpoint inhibitors, medicine.medical_treatment, Muscle invasive, Perioperative, Oncology, medicine, Cancer research, Cisplatin/gemcitabine, business, medicine.drug, Urothelial carcinoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6818d593ad9af4a209311fb58b6aedbfTest
https://doi.org/10.1200/jco.2021.39.6_suppl.430Test

8

Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy

المؤلفون: Pavel Dulguerov, Nicolas Dulguerov, Nicolas Mach, Paolo Scolozzi, Cristina Picardi, Nikolaos Koutsouvelis, Thibault De Maesschalck, Francesca Caparrotti

المصدر: Head & Neck. 38:1695-1702

مصطلحات موضوعية: business.industry, Osteoradionecrosis, medicine.medical_treatment, Incidence (epidemiology), Confounding, Retrospective cohort study, medicine.disease, Radiation therapy, 03 medical and health sciences, 0302 clinical medicine, Otorhinolaryngology, Oropharyngeal Carcinoma, 030220 oncology & carcinogenesis, Medicine, Combined Modality Therapy, 030223 otorhinolaryngology, business, Nuclear medicine, Survival analysis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2ff84e8022087e707168297f7427ccdcTest
https://doi.org/10.1002/hed.24505Test

9

Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08

المؤلفون: Ulrich Mey, Adrian Schmidt, K. Eckhardt, Felicitas Hitz, Thomas Pabst, Simona Berardi Vilei, Clemens B. Caspar, Panagiotis Samaras, Fatime Krasniqi, Christian Rothermundt, Milica Enoiu, Emanuele Zucca, Nicolas Mach, Anne Cairoli, Natalie Fischer, Stephanie Rondeau

المساهمون: University of Zurich, Hitz, Felicitas

المصدر: British Journal of Haematology. 174:255-263

مصطلحات موضوعية: Adult, Male, Bendamustine, medicine.medical_specialty, Lymphoma, B-Cell, medicine.medical_treatment, 2720 Hematology, 610 Medicine & health, Aggressive lymphoma, Sudden death, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Bendamustine Hydrochloride, Humans, Anthracyclines, B-cell lymphoma, Lenalidomide, Aged, Aged, 80 and over, Salvage Therapy, Chemotherapy, business.industry, Remission Induction, Hematology, Middle Aged, medicine.disease, Thalidomide, Surgery, Survival Rate, Regimen, 030220 oncology & carcinogenesis, 10032 Clinic for Oncology and Hematology, Female, Rituximab, business, 030215 immunology, medicine.drug

وصف الملف: Hitz_et_al-2016-British_Journal_of_Haematology.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76766b8123aef7aac72cb2bf0db59106Test
https://doi.org/10.1111/bjh.14049Test

10

SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial

المصدر: Journal of Clinical Oncology. 38:9016-9016

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::da90f4a29e8f5863f7f0a6d6b113d059Test
https://doi.org/10.1200/jco.2020.38.15_suppl.9016Test

تنقيح النتائج